Number of the records: 1
leukotrién A4
SYS d017572 LBL 00000cx--j2200000---45-- 005 20240119200203.5 100 $a 19930604asloy0103----ba0 152 $b mesh 250 $a leukotrién A4 $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 94; was LEUKOTRIENE A (NM) 1980-93 $8 eng 300 1-
$a Arachidonic Acids (1980-1988) $8 eng 300 1-
$a Leukotrienes (1989-1993) $8 eng 330 1-
$a (2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. (From Dictionary of Prostaglandins and Related Compounds, 1990) $8 eng 450 $a LTA4 $5 e $8 eng 450 $a LTA4 $5 e $8 slo 450 $a leukotriény A $5 e $8 slo 686 $a D10.251.355.255.100.450.405 686 $a D10.251.355.310.166.887.405 686 $a D23.469.050.175.450.400 750 $a Leukotriene A4 $8 eng 801 -0
$a US $b DNLM $c 19930604 801 -2
$a SK $b BA006 $c 20000911 801 -2
$a SK $b BA006 $c 20141119 820 $a /biosyn /physiol permitted $8 eng 980 $x M
Number of the records: 1